Paclitaxel and bevacizumab with or without capecitabine as...

European Journal of Cancer 2014 / 12 Vol. 50; Iss. 18

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

Lam, S.W., de Groot, S.M., Honkoop, A.H., Jager, A., ten Tije, A.J., Bos, M.M.E.M., Linn, S.C., van den Bosch, J., Kroep, J.R., Braun, J.J., van Tinteren, H., Boven, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2014.10.008
Date:
December, 2014
File:
PDF, 820 KB
english, 2014
Conversion to is in progress
Conversion to is failed